vs
Side-by-side financial comparison of SOLESENCE, INC. (SLSN) and DNA X, Inc. (SONM). Click either name above to swap in a different company.
DNA X, Inc. is the larger business by last-quarter revenue ($16.2M vs $12.5M, roughly 1.3× SOLESENCE, INC.). SOLESENCE, INC. runs the higher net margin — 1.3% vs -29.3%, a 30.6% gap on every dollar of revenue. On growth, DNA X, Inc. posted the faster year-over-year revenue change (7.9% vs -0.7%). Over the past eight quarters, SOLESENCE, INC.'s revenue compounded faster (12.5% CAGR vs 9.9%).
SLSN vs SONM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $16.2M |
| Net Profit | $163.0K | $-4.8M |
| Gross Margin | 27.5% | 11.2% |
| Operating Margin | 1.5% | -24.5% |
| Net Margin | 1.3% | -29.3% |
| Revenue YoY | -0.7% | 7.9% |
| Net Profit YoY | 129.2% | -89.2% |
| EPS (diluted) | $0.00 | $-4.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.5M | — | ||
| Q3 25 | $14.6M | $16.2M | ||
| Q2 25 | $20.4M | $11.2M | ||
| Q1 25 | $14.6M | $16.7M | ||
| Q4 24 | $12.6M | $15.3M | ||
| Q3 24 | $16.9M | $15.0M | ||
| Q2 24 | $13.0M | $11.5M | ||
| Q1 24 | $9.9M | $9.1M |
| Q4 25 | $163.0K | — | ||
| Q3 25 | $-1.1M | $-4.8M | ||
| Q2 25 | $2.7M | $-7.5M | ||
| Q1 25 | $80.0K | $458.0K | ||
| Q4 24 | $-559.0K | $-21.6M | ||
| Q3 24 | $3.0M | $-2.5M | ||
| Q2 24 | $856.0K | $-6.6M | ||
| Q1 24 | $893.0K | $-2.9M |
| Q4 25 | 27.5% | — | ||
| Q3 25 | 23.1% | 11.2% | ||
| Q2 25 | 28.9% | 7.6% | ||
| Q1 25 | 23.1% | 50.0% | ||
| Q4 24 | 22.0% | -1.2% | ||
| Q3 24 | 36.2% | 28.2% | ||
| Q2 24 | 28.7% | 25.8% | ||
| Q1 24 | 36.3% | 31.8% |
| Q4 25 | 1.5% | — | ||
| Q3 25 | -5.4% | -24.5% | ||
| Q2 25 | 9.4% | -60.2% | ||
| Q1 25 | 1.8% | 3.9% | ||
| Q4 24 | -1.8% | 55.3% | ||
| Q3 24 | 19.0% | -15.8% | ||
| Q2 24 | 8.0% | -56.2% | ||
| Q1 24 | 11.3% | -29.5% |
| Q4 25 | 1.3% | — | ||
| Q3 25 | -7.7% | -29.3% | ||
| Q2 25 | 13.1% | -66.8% | ||
| Q1 25 | 0.5% | 2.7% | ||
| Q4 24 | -4.4% | -141.6% | ||
| Q3 24 | 18.1% | -16.7% | ||
| Q2 24 | 6.6% | -57.5% | ||
| Q1 24 | 9.0% | -31.9% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | $-4.83 | ||
| Q2 25 | $0.04 | $-0.79 | ||
| Q1 25 | $0.00 | $0.08 | ||
| Q4 24 | $0.00 | $-116.99 | ||
| Q3 24 | $0.04 | $-9.32 | ||
| Q2 24 | $0.01 | $-1.41 | ||
| Q1 24 | $0.02 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3M | $2.1M |
| Total DebtLower is stronger | — | $5.1M |
| Stockholders' EquityBook value | $17.6M | $-701.0K |
| Total Assets | $50.1M | $40.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | — | ||
| Q3 25 | $429.0K | $2.1M | ||
| Q2 25 | $4.1M | $2.0M | ||
| Q1 25 | $1.8M | $2.1M | ||
| Q4 24 | $1.4M | $5.3M | ||
| Q3 24 | $2.9M | $9.1M | ||
| Q2 24 | $2.4M | $9.6M | ||
| Q1 24 | $2.0M | $9.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $17.6M | — | ||
| Q3 25 | $17.2M | $-701.0K | ||
| Q2 25 | $18.2M | $-1.3M | ||
| Q1 25 | $15.2M | $-1.1M | ||
| Q4 24 | $14.9M | $-5.7M | ||
| Q3 24 | $15.2M | $15.3M | ||
| Q2 24 | $11.9M | $17.5M | ||
| Q1 24 | $5.0M | $19.8M |
| Q4 25 | $50.1M | — | ||
| Q3 25 | $54.0M | $40.2M | ||
| Q2 25 | $60.0M | $36.1M | ||
| Q1 25 | $57.0M | $36.0M | ||
| Q4 24 | $50.0M | $39.7M | ||
| Q3 24 | $48.0M | $49.1M | ||
| Q2 24 | $40.8M | $45.9M | ||
| Q1 24 | $38.5M | $42.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-7.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 11.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | — | ||
| Q3 25 | $-2.5M | $-7.0M | ||
| Q2 25 | $-654.0K | $-4.9M | ||
| Q1 25 | $-7.2M | $-9.6M | ||
| Q4 24 | $2.2M | $-4.5M | ||
| Q3 24 | $4.2M | $-417.0K | ||
| Q2 24 | $-565.0K | $-3.4M | ||
| Q1 24 | $-3.9M | $-168.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-404.0K | $-4.5M | ||
| Q3 24 | $2.8M | $-554.0K | ||
| Q2 24 | $-1.0M | $-3.4M | ||
| Q1 24 | $-3.9M | $-198.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.2% | -29.6% | ||
| Q3 24 | 16.6% | -3.7% | ||
| Q2 24 | -8.0% | -29.8% | ||
| Q1 24 | -39.9% | -2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.6% | 0.1% | ||
| Q3 24 | 8.3% | 0.9% | ||
| Q2 24 | 3.7% | 0.3% | ||
| Q1 24 | 0.9% | 0.3% |
| Q4 25 | 11.16× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.25× | — | ||
| Q1 25 | -90.26× | -20.97× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.38× | — | ||
| Q2 24 | -0.66× | — | ||
| Q1 24 | -4.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
